Ablation of estrogen receptor alpha (ERalpha) prevents upregulation of POMC by leptin and insulin. - Archive ouverte HAL
Article Dans Une Revue Biochemical and Biophysical Research Communications Année : 2008

Ablation of estrogen receptor alpha (ERalpha) prevents upregulation of POMC by leptin and insulin.

Michi Hirosawa
  • Fonction : Auteur
Mutsuko Minata
  • Fonction : Auteur
Kouji H Harada
  • Fonction : Auteur
Toshiaki Hitomi
  • Fonction : Auteur
Akio Koizumi
  • Fonction : Auteur

Résumé

Diabetic Akita male mice are more hyperphagic because of downregulation of proopiomelanocortin (POMC) caused by hypoleptinemia. We investigated the role of estrogen receptor alpha (ERalpha) in the regulation of the hypothalamic POMC in females. ERaKOAkt mice consumed 30% greater food (g/3 weeks) than the Akita diabetic controls. Ovariectomized diabetic (AFO) and nondiabetic (B6FO) mice had significantly lower food intake and elevated serum leptin levels. ERaKOAkt and ERaKO mice also increased serum leptin concentrations, while hypoinsulinemia was observed in ERaKOAkt and hyperinsulinemia in ERaKO mice. RT-PCR showed a significant attenuation of POMC expression in both ERaKOAkt and ERaKO mice, irrespective of the elevated leptin serum levels or hyperinsulinemia, while elevated serum leptin levels in AFO and B6FO mice upregulated POMC gene expression. These results indicate that ERalpha plays an essential role in leptin- and insulin-stimulated upregulation of the POMC gene. This action of ERalpha is likely mediated in a ligand-independent manner.

Dates et versions

hal-00282966 , version 1 (28-05-2008)

Identifiants

Citer

Michi Hirosawa, Mutsuko Minata, Kouji H Harada, Toshiaki Hitomi, Andree Krust, et al.. Ablation of estrogen receptor alpha (ERalpha) prevents upregulation of POMC by leptin and insulin.. Biochemical and Biophysical Research Communications, 2008, 371 (2), pp.320-3. ⟨10.1016/j.bbrc.2008.04.073⟩. ⟨hal-00282966⟩
71 Consultations
0 Téléchargements

Altmetric

Partager

More